fowey clinical research company limited
fowey clinical research company limited Company Information
Company Number
09009007
Website
www.foweyriverpractice.co.ukRegistered Address
fowey river practice, rawlings lane, fowey, cornwall, PL23 1DT
Industry
General medical practice activities
Telephone
01726829272
Next Accounts Due
June 2025
Group Structure
View All
Shareholders
jill waldron 10%
jan knobloch 10%
View Allfowey clinical research company limited Estimated Valuation
Pomanda estimates the enterprise value of FOWEY CLINICAL RESEARCH COMPANY LIMITED at £15.6k based on a Turnover of £30.5k and 0.51x industry multiple (adjusted for size and gross margin).
fowey clinical research company limited Estimated Valuation
Pomanda estimates the enterprise value of FOWEY CLINICAL RESEARCH COMPANY LIMITED at £0 based on an EBITDA of £-4.9k and a 4.16x industry multiple (adjusted for size and gross margin).
fowey clinical research company limited Estimated Valuation
Pomanda estimates the enterprise value of FOWEY CLINICAL RESEARCH COMPANY LIMITED at £6.4k based on Net Assets of £2.2k and 2.96x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fowey Clinical Research Company Limited Overview
Fowey Clinical Research Company Limited is a live company located in fowey, PL23 1DT with a Companies House number of 09009007. It operates in the general medical practice activities sector, SIC Code 86210. Founded in April 2014, it's largest shareholder is jill waldron with a 10% stake. Fowey Clinical Research Company Limited is a established, micro sized company, Pomanda has estimated its turnover at £30.5k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Fowey Clinical Research Company Limited Health Check
Pomanda's financial health check has awarded Fowey Clinical Research Company Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 5 areas for improvement. Company Health Check FAQs
2 Strong
3 Regular
5 Weak
Size
annual sales of £30.5k, make it smaller than the average company (£1.8m)
- Fowey Clinical Research Company Limited
£1.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (6.3%)
- Fowey Clinical Research Company Limited
6.3% - Industry AVG
Production
with a gross margin of 36.2%, this company has a comparable cost of product (36.2%)
- Fowey Clinical Research Company Limited
36.2% - Industry AVG
Profitability
an operating margin of -16% make it less profitable than the average company (4.7%)
- Fowey Clinical Research Company Limited
4.7% - Industry AVG
Employees
with 1 employees, this is below the industry average (20)
- Fowey Clinical Research Company Limited
20 - Industry AVG
Pay Structure
on an average salary of £31.2k, the company has an equivalent pay structure (£31.2k)
- Fowey Clinical Research Company Limited
£31.2k - Industry AVG
Efficiency
resulting in sales per employee of £30.5k, this is less efficient (£78.5k)
- Fowey Clinical Research Company Limited
£78.5k - Industry AVG
Debtor Days
it gets paid by customers after 37 days, this is near the average (37 days)
- Fowey Clinical Research Company Limited
37 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Fowey Clinical Research Company Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Fowey Clinical Research Company Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 50 weeks, this is more cash available to meet short term requirements (36 weeks)
50 weeks - Fowey Clinical Research Company Limited
36 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 95.4%, this is a higher level of debt than the average (60.4%)
95.4% - Fowey Clinical Research Company Limited
60.4% - Industry AVG
FOWEY CLINICAL RESEARCH COMPANY LIMITED financials
Fowey Clinical Research Company Limited's latest turnover from September 2023 is estimated at £30.5 thousand and the company has net assets of £2.2 thousand. According to their latest financial statements, we estimate that Fowey Clinical Research Company Limited has 1 employee and maintains cash reserves of £43.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | 8 | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 3,091 | 250 | 8,983 | 1,089 | 501 | 16,184 | 10,702 | 25,287 | 600 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 250 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 |
| Cash | 43,114 | 19,462 | 5,139 | 12,411 | 9,524 | 10,174 | 4,908 | 3,711 | 3,201 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 46,455 | 19,712 | 14,122 | 13,500 | 10,025 | 26,358 | 15,610 | 29,098 | 3,801 |
| total assets | 46,455 | 19,712 | 14,122 | 13,500 | 10,025 | 26,358 | 15,610 | 29,098 | 3,801 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,450 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 44,305 | 14,252 | 4,700 | 4,311 | 1,461 | 3,752 | 4,833 | 14,262 | 0 |
| total current liabilities | 44,305 | 14,252 | 4,700 | 4,311 | 1,461 | 3,752 | 4,833 | 14,262 | 5,450 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 44,305 | 14,252 | 4,700 | 4,311 | 1,461 | 3,752 | 4,833 | 14,262 | 5,450 |
| net assets | 2,150 | 5,460 | 9,422 | 9,189 | 8,564 | 22,606 | 10,777 | 14,836 | -1,649 |
| total shareholders funds | 2,150 | 5,460 | 9,422 | 9,189 | 8,564 | 22,606 | 10,777 | 14,836 | -1,649 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Mar 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 3,091 | -8,733 | 7,894 | 588 | -15,683 | 5,482 | -14,685 | 24,787 | 600 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5,450 | 5,450 |
| Accruals and Deferred Income | 30,053 | 9,552 | 389 | 2,850 | -2,291 | -1,081 | -9,429 | 14,262 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | 23,652 | 14,323 | -7,272 | 2,887 | -650 | 5,266 | 1,197 | 510 | 3,201 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 23,652 | 14,323 | -7,272 | 2,887 | -650 | 5,266 | 1,197 | 510 | 3,201 |
fowey clinical research company limited Credit Report and Business Information
Fowey Clinical Research Company Limited Competitor Analysis
Perform a competitor analysis for fowey clinical research company limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in PL23 area or any other competitors across 12 key performance metrics.
fowey clinical research company limited Ownership
FOWEY CLINICAL RESEARCH COMPANY LIMITED group structure
Fowey Clinical Research Company Limited has no subsidiary companies.
Ultimate parent company
FOWEY CLINICAL RESEARCH COMPANY LIMITED
09009007
fowey clinical research company limited directors
Fowey Clinical Research Company Limited currently has 10 directors. The longest serving directors include Mr Terence Dooley (Apr 2014) and Mrs Susan Dooley (Apr 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Terence Dooley | United Kingdom | 69 years | Apr 2014 | - | Director |
| Mrs Susan Dooley | United Kingdom | 69 years | Apr 2014 | - | Director |
| Mr Kristian Soderman | United Kingdom | 47 years | Apr 2014 | - | Director |
| Ms Polly Amos | England | 48 years | Apr 2014 | - | Director |
| Dr Michael Waldron | United Kingdom | 68 years | Apr 2014 | - | Director |
| Dr Richard Cockshott | United Kingdom | 49 years | Apr 2014 | - | Director |
| Dr Paula Marrett | United Kingdom | 50 years | Apr 2014 | - | Director |
| Mrs Jill Waldron | United Kingdom | 75 years | Mar 2017 | - | Director |
| Dr Emmeline Maguire | United Kingdom | 49 years | May 2022 | - | Director |
| Dr Jan Knobloch | United Kingdom | 54 years | May 2022 | - | Director |
P&L
September 2023turnover
30.5k
+1332%
operating profit
-4.9k
0%
gross margin
36.3%
-14.06%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
2.2k
-0.61%
total assets
46.5k
+1.36%
cash
43.1k
+1.22%
net assets
Total assets minus all liabilities
fowey clinical research company limited company details
company number
09009007
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
April 2014
age
10
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
September 2023
address
fowey river practice, rawlings lane, fowey, cornwall, PL23 1DT
accountant
FRANCIS CLARK LLP
auditor
-
fowey clinical research company limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to fowey clinical research company limited.
fowey clinical research company limited Companies House Filings - See Documents
| date | description | view/download |
|---|
